Colposcopy

Area of Science:

• Gynecology
• Cervical Pathology
• Diagnostic Accuracy

Background:

• Colposcopically-directed biopsy (CDB) sensitivity for CIN 3+ has declined from over 90% in the 1980s to 50-65% in recent reviews.
• This decline is attributed to shifts in patient populations, with current clinics evaluating lower-grade cytology and smaller CIN 3+ lesions.
• Inaccurate CDB can skew understanding of CIN natural history, compromise screening practices, and lead to incorrect treatment decisions.

Purpose of the Study:

• To analyze the changing sensitivity of colposcopically-directed biopsy for cervical intraepithelial neoplasia grade 3 and cancer (CIN 3+).
• To identify factors contributing to the decreased accuracy of CDB in contemporary colposcopy clinics.
• To propose improved diagnostic methods to mitigate the harms of inaccurate CIN 3+ diagnosis.

Main Methods:

• Review of historical and recent sensitivity data for colposcopically-directed biopsy (CDB) in detecting CIN 3+.
• Analysis of factors influencing CDB sensitivity, including lesion size and cytology grade.
• Evaluation of the impact of inaccurate CDB on clinical practice and patient outcomes.

Main Results:

• CDB sensitivity for CIN 3+ has significantly decreased since the 1980s.
• Sensitivity is higher for larger CIN 3+ lesions and those associated with high-grade cervical cytology.
• The impression of CIN prevalence on the anterior lip is an artifact of colposcopic inaccuracy.

Conclusions:

• Current colposcopy practices, evaluating lower-risk cytology, result in reduced sensitivity of colposcopically-directed biopsy for CIN 3+.
• Recommendations include random biopsies at the squamocolumnar junction and endocervical curettage (ECC) to improve detection rates.
• ECC may be omitted in women under 25, and smaller biopsy instruments can reduce patient discomfort.